Life Science Companies are Litigation Targets for Unhappy Investors Post author:Sam Post published:February 22, 2018 Post category:BioPharma Life science companies are popular targets for securities fraud litigation. Source: BioSpace You Might Also Like What You Need to Know About Corbin Therapeutics January 14, 2018 <b>BioPharm Executive:</b> Is Biotech "Getting Away With Murder?" January 24, 2017 Pharma Execs are Attractive Candidates for Healthcare Leadership Roles March 22, 2018
